Skip to content

Study of the performance of Centum stent

A cohort study of the performance of Centum stent in patients with acute coronary syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007831
Enrollment
816
Registered
2022-10-21
Start date
2022-07-11
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients of acute coronary syndrome (unstable angina or myocardial infarction) who are over 19 years of age Patients participating voluntarily in the study and who have signed the consent form Patients who have undergone an interventional procedure using Centum stents in the last one month

Exclusion criteria

Exclusion criteria: Subjects with restrictions or hypersensitivity to the following drugs or materials: contrast agent, heparin, aspirin, clopidogrel, everolimus, etc. (Subjects with hypersensitivity to contrast agents may enroll in the study if such reaction can be controlled with steroid or pheniramine. Subjects with a history of anaphylaxis should be excluded.) Subjects who are breast-feeding, pregnant or hoping to become pregnant Subjects with life expectancy of less than 1 year Subjects determined unfit by the investigator

Design outcomes

Primary

MeasureTime frame
Target vessek failure

Secondary

MeasureTime frame
Major adverse cardiac events

Countries

Korea, Republic of

Contacts

Public ContactKyeong Ho Yun

Wonkwang University Hospital

dryunkh@gmail.com+82-63-859-2524

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026